Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
Ziad Hijazi, Senior Medical Director at Thermo Fisher Scientific, shared a post on LinkedIn about a recent article by Maria Tomasdottir et al, published in BMJ journals, adding:
“Refining risk assessment in atrial fibrillation without oral anticoagulation
Our new study shows that NT-proBNP provides important prognostic information in patients with AF not receiving anticoagulation, irrespective of presenting rhythm.
The findings strengthen the evidence underpinning biomarker-based risk stratification in this important but less-studied AF population, with relevance for clinical risk assessment and for patient characterization and enrichment strategies in clinical trials.
Proud to see this work by our PhD student Maria Tomasdottir at Uppsala University published in Heart.”
Title: NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
Authors: Maria Tomasdottir, Jonas Oldgren, Johan Lindbäck, Alexander Benz, John W Eikelboom, Agneta Siegbahn, Lars Wallentin
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:35Archil Jaliashvili: The Real Battle Is Not About Blood Volume — It Is About Oxygen
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation